Abstract
Purpose: FIAU and FEAU were evaluated in vitro and in vivo as markers for HSV1-tk gene expression. Methods: In vitro and biodistribution studies were performed in wild type and transduced HT-29 cells using [14C]FIAU and [3H]FEAU. PET imaging was performed using [18F]FIAU and [18F]FEAU. Results: In vitro uptake of [14C]FIAU in tk-positive cells was 39-fold, 49-fold, and 43-fold higher (p < 0.001) than in wild type cells at 30, 60, and 120 min, respectively. Uptake of [ 3H]FEAU in transduced cells was 46-fold, 62-fold, and 121-fold higher (p < 0.001) than in wild type cells at the same time points. In vivo uptake of [14C]FIAU at 2 h in HSV1-tk positive tumors was 15.48 ± 3.94, 6.7-fold higher (p < 0.001) than in wild type tumors. Uptake of [ 3H]FEAU in transduced tumors was 9.98 ± 1.99, 5.0-fold higher (p < 0.001) than in wild type tumors. Micro-PET images using [ 18F]FIAU and [18F]FEAU also showed very high uptake in HSV-tk tumors. Conclusion: [18F]FIAU and [18F]FEAU appear to be potential PET imaging agents for gene expression.
Original language | English (US) |
---|---|
Pages (from-to) | 822-829 |
Number of pages | 8 |
Journal | European Journal of Nuclear Medicine and Molecular Imaging |
Volume | 34 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2007 |
Keywords
- FEAU
- FIAU
- Gene expression
- HSV-tk
- PET
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging